Zobrazeno 1 - 10
of 123
pro vyhledávání: '"Martin J.B. Taphoorn"'
Autor:
Linda Dirven, Martin J.B. Taphoorn
Publikováno v:
The Lancet Regional Health. Europe, Vol 18, Iss , Pp 100396- (2022)
Externí odkaz:
https://doaj.org/article/3b04db2551a74d74983f29c4c4b3c5e1
Autor:
Marijke B. Coomans, Marthe C.M. Peeters, Johan A.F. Koekkoek, Jan W. Schoones, Jaap Reijneveld, Martin J.B. Taphoorn, Linda Dirven
Publikováno v:
Cancers, Vol 12, Iss 12, p 3502 (2020)
Background: Health-related quality of life (HRQoL) has become an increasingly important patient-reported outcome in glioma studies. Ideally, collected HRQoL data should be exploited to the full, with proper analytical methods. This systematic review
Externí odkaz:
https://doaj.org/article/bb932d57a75344ff98980c64ab58cb06
Autor:
Marthe C.M. Peeters, Hanneke Zwinkels, Johan A.F. Koekkoek, Maaike J. Vos, Linda Dirven, Martin J.B. Taphoorn
Publikováno v:
Cancers, Vol 12, Iss 8, p 2172 (2020)
Background: The aim of this study was to explore the impact of the timing of Health-Related Quality of Life (HRQoL) measurements in clinical care on the obtained HRQoL scores in glioma patients, and the association with feelings of anxiety or depress
Externí odkaz:
https://doaj.org/article/6b97e1c26bde4049ae8f13d961571d90
Autor:
Ivan Caramanna, Jaap C. Reijneveld, Peter M. van de Ven, Martin van den Bent, Ahmed Idbaih, Wolfgang Wick, Martin J.B. Taphoorn, Linda Dirven, Andrew Bottomley, Martin Klein
Publikováno v:
European Journal of Cancer, 186, 38-51. Elsevier Ltd.
European Journal of Cancer, 186, 38-51. Pergamon
Caramanna, I, Reijneveld, J C, van de Ven, P M, van den Bent, M, Idbaih, A, Wick, W, Taphoorn, M J B, Dirven, L, Bottomley, A & Klein, M 2023, ' Association between objective neurocognitive functioning and neurocognitive complaints in recurrent high-grade glioma : Longitudinal evidence of cognitive awareness from EORTC brain tumour trials ', European Journal of Cancer, vol. 186, pp. 38-51 . https://doi.org/10.1016/j.ejca.2023.02.029
European Journal of Cancer, 186, 38-51. Pergamon
Caramanna, I, Reijneveld, J C, van de Ven, P M, van den Bent, M, Idbaih, A, Wick, W, Taphoorn, M J B, Dirven, L, Bottomley, A & Klein, M 2023, ' Association between objective neurocognitive functioning and neurocognitive complaints in recurrent high-grade glioma : Longitudinal evidence of cognitive awareness from EORTC brain tumour trials ', European Journal of Cancer, vol. 186, pp. 38-51 . https://doi.org/10.1016/j.ejca.2023.02.029
Background: Patients’ reduced awareness of neurocognitive functioning (NCF) may negatively affect the reliability of patient-reported outcomes (PROs) and clinical decision-making. This study evaluated cognitive awareness, defined as the association
Autor:
Pim B. van der Meer, Linda Dirven, Marta Fiocco, Maaike J. Vos, Mathilde C.M. Kouwenhoven, Martin J. van den Bent, Martin J.B. Taphoorn, Johan A.F. Koekkoek
Publikováno v:
Neurology, 99(10), E999-E1008. Lippincott Williams & Wilkins
Neurology, 99(10), E999-E1008. LIPPINCOTT WILLIAMS & WILKINS
van der Meer, P, Dirven, L, Fiocco, M, Vos, M J, Kouwenhoven, M C M, van den Bent, M J, Taphoorn, M J B & Koekkoek, J A F 2022, ' Effectiveness of Antiseizure Medication Duotherapies in Patients With Glioma : A Multicenter Observational Cohort Study ', Neurology, vol. 99, no. 10, pp. E999-E1008 . https://doi.org/10.1212/WNL.0000000000200807
Neurology, 99(10), e999-e1008. LIPPINCOTT WILLIAMS & WILKINS
Neurology, 99(10), E999-E1008. Lippincott Williams and Wilkins
Neurology, 99(10), E999-E1008. LIPPINCOTT WILLIAMS & WILKINS
van der Meer, P, Dirven, L, Fiocco, M, Vos, M J, Kouwenhoven, M C M, van den Bent, M J, Taphoorn, M J B & Koekkoek, J A F 2022, ' Effectiveness of Antiseizure Medication Duotherapies in Patients With Glioma : A Multicenter Observational Cohort Study ', Neurology, vol. 99, no. 10, pp. E999-E1008 . https://doi.org/10.1212/WNL.0000000000200807
Neurology, 99(10), e999-e1008. LIPPINCOTT WILLIAMS & WILKINS
Neurology, 99(10), E999-E1008. Lippincott Williams and Wilkins
Background and ObjectivesAbout 30% of patients with glioma need an add-on antiseizure medication (ASM) due to uncontrolled seizures on ASM monotherapy. This study aimed to determine whether levetiracetam combined with valproic acid (LEV + VPA), a com
Autor:
Fleur H.J. Kaptein, Milou A.M. Stals, Maaike Y. Kapteijn, Suzanne C. Cannegieter, Linda Dirven, Sjoerd G. van Duinen, Ronald van Eijk, Menno V. Huisman, Eva E. Klaase, Martin J.B. Taphoorn, Henri H. Versteeg, Jeroen T. Buijs, Johan A.F. Koekkoek, Frederikus A. Klok
Publikováno v:
Journal of Thrombosis and Haemostasis, 20(7), 1665-1673. Wiley-Blackwell
Journal of Thrombosis and Haemostasis, 20(7), 1665-1673. WILEY
Journal of Thrombosis and Haemostasis, 20(7), 1665-1673. WILEY
Background: Glioblastoma patients are considered to be at high risk of venous thromboembolism (VTE) and major bleeding (MB), although reliable incidence estimates are lacking. Moreover, the risk of arterial thromboembolism (ATE) in these patients is
Autor:
Pim B. van der Meer, Linda Dirven, Marta Fiocco, Maaike J. Vos, Mathilde C.M. Kouwenhoven, Martin J. van den Bent, Martin J.B. Taphoorn, Johan A.F. Koekkoek
Publikováno v:
Neurology, 100(14), E1488-E1496. Lippincott Williams and Wilkins
Neurology, 100(14), E1488-E1496. Lippincott Williams & Wilkins
van der Meer, P B, Dirven, L, Fiocco, M, Vos, M J, Kouwenhoven, M C M, van den Bent, M J, Taphoorn, M J B & Koekkoek, J A F 2023, ' Effectiveness of Antiseizure Medication Triple Therapy in Patients with Glioma with Refractory Epilepsy : An Observational Cohort Study ', Neurology, vol. 100, no. 14, pp. E1488-E1496 . https://doi.org/10.1212/WNL.0000000000206852
Neurology, 100(14), E1488-E1496. Lippincott Williams & Wilkins
van der Meer, P B, Dirven, L, Fiocco, M, Vos, M J, Kouwenhoven, M C M, van den Bent, M J, Taphoorn, M J B & Koekkoek, J A F 2023, ' Effectiveness of Antiseizure Medication Triple Therapy in Patients with Glioma with Refractory Epilepsy : An Observational Cohort Study ', Neurology, vol. 100, no. 14, pp. E1488-E1496 . https://doi.org/10.1212/WNL.0000000000206852
Background and ObjectivesApproximately 10% of patients with glioma with epilepsy need antiseizure medication (ASM) triple therapy due to refractory epilepsy. The aim of this study was to evaluate whether levetiracetam combined with valproic acid and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6477ea68dd976ba4028bfebb1f5b4266
https://research.vumc.nl/en/publications/df3d90c5-8c5f-47af-96da-44fac9934a02
https://research.vumc.nl/en/publications/df3d90c5-8c5f-47af-96da-44fac9934a02
Autor:
Pim J. French, Martin J. van den Bent, Pierre A. Robe, Ahmed Idbaih, Thierry Gorlia, Vassilis Golfinopoulos, Corneel Coens, Tina Verschuere, Johan M. Kros, Olivier L. Chinot, Michael Weller, Martin J.B. Taphoorn, Paul J. Mulholland, Antje Wick, Filip Y.F. de Vos, Paul M. Clement, Jaap C. Reijneveld, Marion Smits, Martin Klein, Iris de Heer, C. Mircea S. Tesileanu, Kaspar Draaisma
Supplementary Figure from Prognostic Significance of DNA Methylation Profiles at MRI Enhancing Tumor Recurrence: a Report from the EORTC 26091 TAVAREC Trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09e4bda6d2dc6c6b0083079ad27f6793
https://doi.org/10.1158/1078-0432.22487001
https://doi.org/10.1158/1078-0432.22487001
Autor:
Pim J. French, Martin J. van den Bent, Pierre A. Robe, Ahmed Idbaih, Thierry Gorlia, Vassilis Golfinopoulos, Corneel Coens, Tina Verschuere, Johan M. Kros, Olivier L. Chinot, Michael Weller, Martin J.B. Taphoorn, Paul J. Mulholland, Antje Wick, Filip Y.F. de Vos, Paul M. Clement, Jaap C. Reijneveld, Marion Smits, Martin Klein, Iris de Heer, C. Mircea S. Tesileanu, Kaspar Draaisma
Purpose:Despite recent advances in the molecular characterization of gliomas, it remains unclear which patients benefit most from which second-line treatments. The TAVAREC trial was a randomized, open-label phase II trial assessing the benefit of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::532142765998775af1347106878dfffb
https://doi.org/10.1158/1078-0432.c.6532437
https://doi.org/10.1158/1078-0432.c.6532437
Autor:
Monika E. Hegi, Gianfranco Pesce, Benoit Lhermitte, Krisztian Homicsko, Kirsten Hopkins, Astrid Weyerbrock, Salvador Villa, Christine Marosi, Damien Ricard, Mario Campone, Jean-Sebastien Frenel, Vassilis Golfinopoulos, Patrick Roth, Roger Stupp, Michael Weller, Markus Kosch, Antje Wick, Marie-France Hamou, Alba A. Brandes, Jonathan Steuve, Martin J.B. Taphoorn, Martin J. van den Bent, Michael Platten, Pierre Bady, Thierry Gorlia, Wolfgang Wick
Suppl. Materials and Methods; 5 Suppl. Figures; 2 Suppl Tables and List of Participating Investigators Supplementary Figure S1. Definition of MGMT cut-off with a safety margin. Supplementary Figure S2. Comparison of Overall Survival in patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7abf627cd68b404f5ebaed5b79d96a4c
https://doi.org/10.1158/1078-0432.22467896
https://doi.org/10.1158/1078-0432.22467896